ABSTRACT. We hypothesized that developmental in-(1) have shown that increases in both ventricular EDP and creases in both ventricular end-diastolic pressure (EDP) maximum dP/dt occur concurrently with CL decrease (heart and the maximum time derivative of pressure (dP/dt) ob-rate increase) from d 2 to 6 (Hamburger-Hamilton stages 12 to served in stage 12 to 29 chick embryos are the result of 29) of a 21-d incubation. observed cardiac cycle length (CL) decrease (heart rate
long CL and because of the shortcomings of the quadratic regression model at very long CL, these points were discarded and the reported results are limited to CL < 1500 ms.
Results from a single study show that as the CL increased, the EDP asymptotically increased (Fig. 3A) . The regression line for each study and a composite regression line for all studies is shown in Figure 3B . For the 18 embryos. the average EDP increased from 0.043 to 0.092 kPa as the CL increased from 200 to 1500 ms.
On the other hand, results from a single study show that maximum dP/dt asymptotically decreased as CL increased (Fig.  4A) . The regression for each study and a composite regression line for all studied is shown in Figure 4B . For the 18 embryos, the average maximum dP/dt decreased from 6.67 to 3.20 kPa/s as the CL increased from 200 to 1500 ms. DISCUSSION Our study was designed to test the hypothesis that observed developmental increase in ventricular EDP and maximum dP/ dt are the result of concurrent changes in cardiac CL. We found that in the stage 24 chick embryo the EDP increased as CL increased. This direct relationship is contrary to that observed during embryonic development. However, the maximum dP/dt decreased when CL increased, which is similar to the reciprocal relationship observed during development. Only acute CL changes were observed in our study. It is not clear if chronic CL changes would have similar effects on EDP and dP/dt. 
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Fig. 4 . Relationship of maximum dP/dt and CL. Panel A shows a quadratic regression plot of the relation between dP/dt and CL for a single embryo. The R2 of the regression curve is 0.63. Panel B shows a composite plot of the relation of maximum dP/dt to cycle length. The thin lines represent the individual regression curves for each of the 18 embryos. The thick line is the regression curve for all data points. The R2 of the average regression is 0.54.
The relationship between maximum dP/dt and CL found in the stage 24 embryo suggests that maximum dP/dt increase during developmental stages 12 to 29 may be a function of developmental CL decrease, exclusive of structural changes occurring to the embryonic heart.
The positive inotropic effect of decreasing the CL (so-called "treppe" phenomenon) was first described by Bowditch (3). This relationship has since been recognized in the fetal, neonatal, and mature mammalian heart (4, 5) . Results of our study show a similar relationship in the stage 24 embryonic chick heart.
As previously reviewed (5), most studies in the fetal, neonatal, and mature mammalian heart report a decrease or no change in EDP during CL decrease. A similar relationship was found in this study for the stage 24 chick embryo. Thus, developmental EDP increase cannot be accounted for by CL decrease. Developmental EDP increase might be the result of changes in cardiac geometry-morphology, myocyte function, or both. In the chick embryo, the heart develops from a thin-walled tube at stage 12 to a sponge-like single ventricle at stage 24 and finally to a thickwalled, four-chambered pump at stage 29 (6) . During the same developmental stages, the average weight of the ventricles increases 30-fold from 0.1 (stage 12) to 3.18 mg (stage 29), and the average weight of embryo increases 100-fold from 2.22 to 267.5 mg, respectively (1, 7) . The ventricular shortening fraction changes very little (8) . Diastolic functional changes associated with these dramatic changes in cardiac structure include an increase in EDP as well as a decrease in the ratio of passive to active filling components of the atrioventricular filling velocity (9) . The later change has been interpreted as indicating a decrease in the compliance of the ventricle as the embryo matures. A compliance decrease might account for the observed developmental increase in EDP. We did not evaluate compliance in this study as we did not measure ventricular volume. Rapid changes at the myocyte level also occur during embryonic chick cardiac development. Myocytes begin to develop myofibrils during stages 9 or 10; initially there is an increase in the proportion of myofibril-cell volume, but then a decrease as niyofibrils become more organized presumably by aligning along lines of stress (7) . There appears to be little or no change in ventricular myofibrillar myosin during cardiogenesis of the chick embryo (10) . On the other hand, developmental studies of myocardial calcium transport have shown that sarcolemmal Na-Ca exchange is the primary mechanism of calcium transport in the young chick embryo, whereas sarcoplasmic reticulum calcium uptake plays the predominate role in calcium transport in the newborn and adult chicken (1 1). It is possible that developmental changes in the calcium transport network and their role in ventricular relaxation contribute to the developmental changes in ventricular EDP.
Use of the thermal probe technique for heart rate perturbation avoids some of the problems encountered by methods previously employed to alter CL. Environmental hypothermia (12) and hyperthermia (1 3) affect the systemic vascular resistance as well as alter the CL. The thermal probe limits temperature effects to the sinus venosus, resulting in an isolated CL change. Previous studies with the thermal probe technique showed that there is a linear relationship between CL and stroke volume (14) . The CL and stroke volume relationship is identical for heart rate increase with sinus venosus pacing or application of a heated probe. Sinus venosus pacing alters CL, but the electronic interference of the pacing stimulus prevents pressure measurement with the servonull system (15) .
Defining the relationship between form and function of the developing cardiovascular system is important to understanding the formation of the heart. Further investigation of the hemodynamic, morphologic, and cellular changes occurring in the embryonic heart will help to delineate normal and abnormal mechanisms of development. ABSTRACT. The proposed actions of atrial natriuretic factor (ANF) are mediated through specific plasma membrane (R,) receptors coupled to guanylate cyclase. A second receptor, Rz, has been characterized by its ability to bind to an acyclic, truncated ANF analog (C-ANF4-23). The ANF-R2 receptor has not been identified in the fetus. Our study was conducted to determine the effects of C-ANF on fetal renal and cardiovascular function and plasma ANF clearance rates. Chronically catheterized ovine fetuses (n = 6) at 111 to 117 d gestation (term 145 d) received a C-ANF infusion (1 wg/min/kg) for 30 min followed by a combined infusion of C-ANF and ANF (C-ANF, 1 wg/min/ kg; ANF, 100 ng/min/kg) for an additional 30 min. C-ANF infusion significantly increased (mean 2 SEM) plasma ANF concentration (437 f 45 to 1067 f 297 pg/mL), urinary flow rate (0.26 f 0.04 to 0.38 2 0.07 mL/min/kg), sodium excretion (12.9 f 3.5 to 21.7 f 6.1 LLmol/min/kg), and osmolar clearance (0.14 f 0.02 to 0.21 f 0.04 mL/ min/kg) ( p < 0.05). The combined C-ANFIANF infusion further increased plasma ANF concentration to 2394 f 532 pg/mL and resulted in significant increases in urinary flow rate, sodium excretion, osmolar clearance, GFR, and free water clearance compared with C-ANF infusion alone ( p < 0.05). These renal responses, however, were not significantly different from the responses to ANF infusion alone (100 ng/min/kg). Although the calculated mean ANF plasma clearance rate during the combined C-ANF/ANF infusion (77 f 16 mL/min/kg) was lower than previously observed in more mature fetal lambs, the value was not different from the mean ANF plasma clearance rate calculated during ANF infusion alone (68 2 15 mL/min/kg). The response to the C-ANF infusion suggests displacement of ANF from renal ANF-R2 receptors, supporting the presence of Rz receptors in the ovine fetus. However, these findings indicate that receptor-mediated ANF clearance does not significantly contribute to overall fetal plasma ANF clearance at this early gestational age. 
PCAN-ANF plasma clearance rate
The cardiac atria secrete a group of structurally related p e p tides, termed ANF, that evoke potent natriuretic, diuretic, and vasodilatory effects in adult animals and man (l,2). The multiple effects of ANF are mediated through specific plasma membrane receptors located in numerous target tissues, including vascular endothelial and smooth muscle cells, renal glomerular epithelial and mesangial cells, the renal papillae, adrenal, and pituitary glands, and various brain regions (3). At least two distinct types of ANF receptors have been proposed based on estimates of receptor size. One receptor, R,, is coupled to guanylate cyclase and is proposed to mediate the known physiologic actions of ANF on target tissues through the production of cyclic GMP (4). A second ANF receptor, R1, is not coupled to guanylate cyclase and is characterized by its ability to bind to various truncated and ring-deleted analogs of ANF (5, 6) . Although the ANF-RZ receptors have been postulated to serve an ANF storage/clearance function (7), recent data indicate that ANF binding to these receptors stimulates phosphoinositol hydrolysis (8) and inhibits adenylate cyclase and CAMP production (9) . The significance of these second messenger effects is not yet clear.
The ontogeny and function of ANF receptors during fetal maturation have not been extensively studied. Placental (ANF) receptors have been isolated in various mammalian species (1 0, 11) including man (12) . Renal glomerular ANF receptors have been described as early as 108 d gestation in the ovine fetus (term = 145 d); ANF binding capacity of the glomerular receptor was shown to increase with gestational age (13) . However, the physiologic significance of the placental and glomerular receptors is unclear. The ANF-R2 receptor has not been identified in the fetus. In the present paper, we report studies of the effects of C-ANF (an ANF-R2 receptor ligand) on ANF kinetics and actions in the fetal sheep conducted to assess the presence and possible significance of fetal ANF-R2 receptors.
MATERIALS AND METHODS
Animals and surgery. Six Western cross-bred pregnant ewes with singleton fetuses ranging in age from 1 1 1 to 1 17 d (mean gestational age 1 14 k 1 d, n = 6) were studied. Ovine fetuses at this early &station have been previously shown to be more responsive to the elevation of plasma ANF concentration than older fetuses or newborn lambs (14, 15) . Animals were housed indoors in individual steel study cages and maintained under a controlled lighting regimen (1 2 h of light and 12 h of dark). Both food (alfalfa pellets) and water were available ad libitum, except that food was withheld during the 24-h period immediately preceding surgery.
ANF ANALOGUE IN THE OVINE FETUS 343
Anesthesia for surgery was induced by an intramuscular injection of ketamine hydrochloride (10 mg/kg) plus atropine sulfate (30 pg/kg), and subsequently maintained by a continuous i.v. ketamine infusion (1 5 mg/k/kg). Xylocaine (1 %) was applied locally before all incisions. The pregnant ewe's uterus was exposed by a midline abdominal incision and a small hysterotomy was performed to provide access to a single fetal hindlimb. Tygon catheters (1 mm inner diameter; 1.8 mm, outer diameter) were placed in the fetal dorsal hindlimb vein and artery and threaded to the inferior vena cava and abdominal aorta, respectively. Before hysterotomy closure, a plastic catheter (Corometrics Medical Systems, Wallingford, CT) was sutured to the distal tip of the fetal hindlimb to measure amniotic fluid pressure. The hindlimb was returned into the uterus and the hysterotomy was closed in two layers.
A second hysterotomy was performed to provide access to the fetal abdomen. The fetal abdomen was incised longitudinally (4 cm) and the fetal skin marsupialized to the uterus with clamps. The fetal bladder was exposed and 1.5 cm of a Tygon catheter (inner diameter = 1.3 mm, outer diameter = 2.3 mm) with multiple ports was secured to the lining of the bladder by a pursestring suture. The fetal peritoneum and skin were closed as separate layers around the bladder catheter. The uterus, maternal fascia, and skin were closed in separate layers with sutures. The maternal femoral artery and vein were catheterized in one leg and the catheters threaded to the aorta and inferior vena cava, respectively.
All catheters were exteriorized to the maternal flank and placed in a cloth pouch sewn to the ewe's flank. Fetal vascular catheters were maintained patent by filling the catheter dead space (1 mL) with 1000 U/mL sodium heparin; catheters were sealed with sterile plastic caps. Maternal vascular catheters were filled with heparinized saline (10 U/mL) and both fetal and maternal catheters were flushed daily. Immediately after surgery, as well as twice daily for the succeeding 7 d, fetuses received an i.v. infusion of oxacillin (100 mg) and gentamicin (8 mg); oxacillin (400 mg), gentamicin (72 mg), and chloramphenicol (500 mg) also were administered into the maternal vein and amniotic cavity.
Experimental protocol. All experiments were performed on unanesthetized ewes standing in the same individual cages in which they were maintained. Fetal studies were undertaken only if the fetal arterial pH was greater than 7.35 and the fetal urine osmolality was less than 170 mosmol/kg water. Both values are sensitive markers of fetal well being.
Experiments were initiated by allowing the fetal bladder catheters to drain by gravity and beginning i.v. infusions of 0.9% NaCl(0.05 mL/min/kg) and 3H-inulin (10 &i/h) in 0.9% NaCl (0.12 mL/min). After equilibration for 30 min, fetal urine was collected at 10-min intervals for 30 rnin (control period; time = 0 to 30 rnin). During the subsequent 30 min, 0.9% NaCl (0.05 mL/min/kg) containing synthetic C-ANF (4-23) (Bachem Inc., Torrance, CA) was administered to the fetuses ( n = 6) at 1 fig/ min/kg (30 to 60 rnin). This dose of C-ANF was selected on the basis of the experience of Maack et al. (7) , who demonstrated major increases in plasma ANF levels and urinary sodium excretion after its administration to intact rats. Fetuses then received a combined infusion of C-ANF (1 pg/min/kg) and ANF (100 ng/min/kg) for an additional 30 rnin (60 to 90 min). After the C-ANF/ANF infusion, the fetuses received 0.9% NaCl infusions and were monitored for an additional 30-min recovery period (90 to 120 min). To compare the physiologic responses, ANF alone (100 ng/min/kg) was infused into the same six catheterized fetuses randomly on either the previous or subsequent day using the same protocol. Fetal time-control experiments with 0.9% NaCl (vehicle) infusion at 0.05 mL/min/kg and 3H-inulin (10 pCi/h) in 0.9% NaCl at 0.12 mL/min were performed in five fetuses using a similar protocol. Infusion concentrations were based on estimated fetal body weight (FBW) from the following formula (14): Fetal and adult arterial blood samples for ANF determinations were collected at 10, 20, and 30 min of each of the 30-min infusion periods and placed in tubes containing EDTA (1 mg/ mL), Traysylol (250 kallikrein inhibitor units/mL) and soybean trypsin inhibitor (50 benzyl-L-arginine ethyl ester units/mL). All samples were centrifuged immediately at 4°C and the plasma for ANF assay was separated and stored at -20°C until extracted. The remaining aliquoted plasma was utilized for measurements of osmolality, sodium and potassium concentrations, and 'Hinulin activity. Additional blood samples (0.5 mL) were collected into heparinized tuberculin syringes at the end of each period for immediate measurement of pH, P02, and Pco~.
The total volume of fetal blood withdrawn at each sampling (4.0-4.5 mL) was replaced with an equal volume of heparinized maternal blood withdrawn before the study. Arterial blood and amniotic cavity pressures were monitored continuously by means of a Beckman R-6 12 physiologic recorder (Beckman Instruments, Irvine, CA) with Statham P23 transducers (Sensormedics, Fullerton, CA). Fetal blood pressure was corrected for amniotic fluid pressure and heart rate was computed from the arterial pulse. At the end of each urine collection period (10 min), urine volume was measured and aliquots were analyzed for osmolality, sodium and potassium concentrations, and 3H-inulin levels.
Analytical methods. Plasma ANF samples were extracted with --C-18 Sep Pak columns (Waters Associates, Medford, MA) and ANF levels were determined by RIA as previously described (1 5).
The sensitivity of the assay, defined by the least amount of added ANF distinguishable from zero tubes at the 95% confidence limit, was 2 pgltube. The intraassay and interassay coefficients of variation were 1 1 and 13%, respectively.
Blood pH, Poz, and Pcoz values were determined at 39°C with 
Maternal arterial measurements.
There were no changes from basal values of maternal hematocrit, pH, Po2, PCOL, plasma osmolality, or ANF concentrations during the course of the study (Table 1) .
Fetal arterial measurements. The antiserum used in the ANF RIA was 100% cross-reactive with human ANF (1-28 amino acids); cross-reaction with C-ANF was less than 0.02% on a molar basis (Fig. 1) . Because no differences were found in plasma ANF concentrations at 10, 20, and 30 min of each infusion period, plasma and urinary data were expressed as the mean value of each respective period. Data during ANF infusion alone is presented with the C-ANF infusions; control and recovery data did not differ. Fetal plasma ANF concentrations increased from control values of 477 + 45 to 1067 a 297 pg/mL ( p < 0.05) during the C-ANF infusion and increased further to 2394 + 532 pg/mL during the combined C-ANFIANF infusion (Fig. 2) . The mean plasma ANF concentration observed during the combined C-ANF or C-ANF/ANF infusion was not different than obtained with ANF infusion alone (1866 k 482 pg/mL). The estimated mean fetal PCANF during the combined C-ANF/ANF infusion was 77 * 16 mL/min/kg versus 68 + 15 mL/min/kg with ANF infusion alone.
The infused C-ANF and combined C-ANF/ANF had no significant effects on fetal arterial pH, Po2, Pco~, or mean arterial blood pressure ( Table 2 ). The combined C-ANF/ANF infusion produced significant increases in fetal heart rate and hematocrit not evident with the C-ANF infusion. A similar response in fetal heart rate and hematocrit was observed during ANF infusion alone (Table 2) .
In response to the C-ANF infusion, fetal urine flow rate, sodium excretion, and osmolar excretion increased significantly ( p < 0.05) over basal values (Fig. 3) . The combined C-ANF/ ANF infusion evoked increases in urine flow rate, sodium excretion, and osmolar excretion values that were significantly greater : p < 0.05) than were observed in response to C-ANF alone. The mean responses of fetal urine flow rate, sodium excretion, and ~smolar excretion to ANF infusion alone did not differ from the responses obtained with C-ANF or the combined C-ANF/ANF infusion (Fig. 3) .
As shown in Figure 4 , increases in both GFR and free water :learance were noted during the C-ANF infusion. However, the falues did not differ significantly from control values. The com3ined C-ANF/ANF infusion evoked further increases that were iignificantly greater ( p < 0.05) than control values. The GFR ind free water clearance responses induced by ANF infusion ilone also were significantly greater than control values but did lot differ from the responses observed during combined C-ANF/ \NF infusion. excretion; Cosm, osmolar clearance; CH20, free water clearance.
No changes in fetal plasma ANF levels or renal function were observed during infusion of 0.9% NaCl in fetal sheep ( Table 3) . DISCUSSION The ANF receptor exists in several forms, including a 120-to 135-kD guanylate cyclase (R,) and a 66-to 70-kD truncated protein lacking most of the intracellular domain (R2) (4, 5) . The former binds the major circulating form of ANF (ANF99-196), and binding results in the activation of guanylate cyclase and increased cyclic GMP production (4). The truncated receptor, the more abundant receptor form in most tissues, accepts a wider range of ANF structures, but ligand binding does not evoke cyclic GMP generation (1 6, 17) . When originally described, the R2 receptor was proposed to modulate circulating ANF levels by serving as a storage/clearance site (7, 18) . More recently, ANFRl receptor activation has been reported to stimulate phosphoinositol hydrolysis (8) and inhibit the adenylate cyclase/cAMP system (9). These observations suggest that ANF-R2 receptors exert direct biologic effects via the phosphoinositol system and modulate the adenylate cyclase system to other hormones. However, the physiologic importance of these effects remains to be investigated.
The dose of C-ANF used in our study was previously shown to produce a biologic effect in adult small animals (7, 19) . In agreement with these earlier observations, C-ANF infusion into fetal sheep evoked significant increases in fetal plasma ANF concentration and the combined C-ANF/ANF infusions produced a further increase in fetal ANF concentration (1067 + 297 to 2394 + 532 pg/mL). Because C-ANF is not immunoreactive in the ANF RIA system, the increase in plasma ANF concentration observed during C-ANF infusion represents either increased ANF secretion or occupation of ANF-R2 receptors with displacement of endogenous ANF (7, 19) . The control (saline) infusion did not evoke ANF release, and there is no evidence that C-ANF stimulates cardiac ANF secretion. The observed increases in urine flow rate, GFR, osmolar clearance and sodium excretion are consistent with a C-ANF-induced increase in plasma ANF receptors. However, because the fetal plasma ANF levels and PCANF values were statistically similar during ANF alone and combined C-ANF/ANF infusion (2394 + 532 versus 1866 -+. 482 pg/mL, and 68 + 15 versus 77 + 16 mL/kg/min, respectively), these data do not support a clearance role for R2 receptors in the fetus.
The increases in urine flow rate, sodium excretion, and osmolar clearance observed in response to C-ANF infusion apparently resulted from increased plasma ANF concentrations as already discussed. Although not statistically significant, mean GFR and free water clearance increased 49 and 27% during C-ANF infusion relative to the control period. The combined C-ANF/ANF infusions evoked further significant increases in urine flow rate, sodium excretion, osmolar clearance, GFR, and free water clearance (Figs. 3 and 4) . However, the responses to combined C-ANF/ ANF infusion were not different from the effects of ANF infusion alone, suggesting that a plateau in the renal response to ANF is achieved at plasma ANF levels less than 1800 pg/mL. The significant fetal renal responses to increased plasma ANF concentrations are consistent with previous
